Login / Signup

Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study.

Jessica R Howard-AndersonMichelle DavisAlexander M PageChris W BowerGillian SmithJesse T JacobDan I AnderssonDavid S WeissSarah W Satola
Published in: The Journal of antimicrobial chemotherapy (2022)
Colistin heteroresistance was identified in up to 26% of patients with CRPA in our sample, although the prevalence varied depending on the definition. We did not observe an apparent association between colistin heteroresistance and 90 day mortality.
Keyphrases